Literature DB >> 21516357

Proteomic analysis of glycated proteins from streptozotocin-induced diabetic rat kidney.

Ashok D Chougale1, Shweta P Bhat, Swapnil V Bhujbal, Mandar R Zambare, Shraddha Puntambekar, Rahul S Somani, Ramanamurthy Boppana, Ashok P Giri, Mahesh J Kulkarni.   

Abstract

Glycation of proteins leading to formation of advanced glycation end products (AGEs) has been considered as one of the important causes of diabetic nephropathy. Therefore, in this study, glycated proteins were detected by anti-AGE antibodies from kidney of streptozotocin-induced diabetic rat showing nephropathic symptoms, by using two dimensional electrophoresis and western blot analysis. These glycated proteins were identified and characterized by using combination of peptide mass finger printing and tandem mass spectrometric approaches. Glycated proteins identified included proteins from metabolic pathways, oxidative stress, cell signaling, and transport. Several of the proteins modified by glycation were involved in glucose metabolism. The extent of glycation was higher in diabetes compared to control, in the glycated proteins that were common to both control and diabetic kidney. Two dimensional electrophoresis proteins profiling of glycated proteins suggest that four of the glycated proteins were significantly up regulated in diabetes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21516357     DOI: 10.1007/s12033-011-9409-3

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  47 in total

1.  Albumin competitively inhibits glycation of less abundant proteins.

Authors:  Hemangi S Bhonsle; Sameer Kumar Singh; Ghanshyam Srivastava; Ramanamurthy Boppana; Mahesh J Kulkarni
Journal:  Protein Pept Lett       Date:  2008       Impact factor: 1.890

2.  Yeast protein glycation in vivo by methylglyoxal. Molecular modification of glycolytic enzymes and heat shock proteins.

Authors:  Ricardo A Gomes; Hugo Vicente Miranda; Marta Sousa Silva; Gonçalo Graça; Ana V Coelho; António E Ferreira; Carlos Cordeiro; Ana Ponces Freire
Journal:  FEBS J       Date:  2006-10-25       Impact factor: 5.542

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Inactivation and conformation changes of the glycated and non-glycated D-glyceraldehyde-3-phosphate dehydrogenase during guanidine-HCl denaturation.

Authors:  R Q He; Y G Li; X Q Wu; L Li
Journal:  Biochim Biophys Acta       Date:  1995-11-15

5.  Inactivation of glyceraldehyde 3-phosphate dehydrogenase by sugars, prednisolone-21-hemisuccinate, cyanate and other small molecules.

Authors:  D W Hook; J J Harding
Journal:  Biochim Biophys Acta       Date:  1997-12-31

6.  Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.

Authors:  Nozomu Tanji; Glen S Markowitz; Caifeng Fu; Thomas Kislinger; Akihiko Taguchi; Monika Pischetsrieder; David Stern; Ann Marie Schmidt; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2000-09       Impact factor: 10.121

7.  Methylglyoxal can modify GAPDH activity and structure.

Authors:  Hyon Jae Lee; Scott K Howell; Rebecca J Sanford; Paul J Beisswenger
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

8.  Oxidative stress and advanced glycation in diabetic nephropathy.

Authors:  Melinda T Coughlan; Amy L Mibus; Josephine M Forbes
Journal:  Ann N Y Acad Sci       Date:  2008-04       Impact factor: 5.691

9.  Glycation (non-enzymic glycosylation) inactivates glutathione reductase.

Authors:  R Blakytny; J J Harding
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

10.  Glycation-induced inactivation of malate dehydrogenase protection by aspirin and a lens molecular chaperone, alpha-crystallin.

Authors:  M M Heath; K C Rixon; J J Harding
Journal:  Biochim Biophys Acta       Date:  1996-04-12
View more
  5 in total

Review 1.  Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.

Authors:  Megan Jack; Douglas Wright
Journal:  Transl Res       Date:  2012-01-10       Impact factor: 7.012

2.  Proteomic Insight Reveals Elevated Levels of Albumin in Circulating Immune Complexes in Diabetic Plasma.

Authors:  Shweta Bhat; Mashanipalya G Jagadeeshaprasad; Yugendra R Patil; Mahemud L Shaikh; Bhaskaran S Regin; Viswanathan Mohan; Ashok P Giri; Muthuswamy Balasubramanyam; Ramanamurthy Boppana; Mahesh J Kulkarni
Journal:  Mol Cell Proteomics       Date:  2016-04-07       Impact factor: 5.911

3.  Proteomic analysis of protease resistant proteins in the diabetic rat kidney.

Authors:  Sneha B Bansode; Ashok D Chougale; Rakesh S Joshi; Ashok P Giri; Subhash L Bodhankar; Abhay M Harsulkar; Mahesh J Kulkarni
Journal:  Mol Cell Proteomics       Date:  2012-11-01       Impact factor: 5.911

Review 4.  Proteomics and systems biology for understanding diabetic nephropathy.

Authors:  Jonathan M Starkey; Ronald G Tilton
Journal:  J Cardiovasc Transl Res       Date:  2012-05-12       Impact factor: 4.132

Review 5.  Proteomics in India: the clinical aspect.

Authors:  Somaditya Mukherjee; Arun Bandyopadhyay
Journal:  Clin Proteomics       Date:  2016-11-05       Impact factor: 3.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.